Sharyn Alfonsi reports on the unusual path fluvoxamine, a drug commonly used to treat obsessive-compulsive disorder, has had to becoming an early treatment candidate for COVID-19
Finding a possible early treatment for COVID-19 in a 40-year-old antidepressant
View Content